Unique Proteome Signature of Post-Chemotherapy Ovarian Cancer Ascites-Derived Tumor Cells

Scientific Reports - United Kingdom
doi 10.1038/srep30061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Myxoma Virus-Mediated Oncolysis of Ascites-Derived Human Ovarian Cancer Cells and Spheroids Is Impacted by Differential AKT Activity

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Clinical Implications of Circulating Tumor DNA From Ascites and Serial Plasma in Ovarian Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Inhibition of Natural Killer Activity by Tumor-Associated Lymphoid Cells From Ascites Ovarian Carcinomas23

Journal of the National Cancer Institute
Cancer ResearchOncology
1981English

Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy

Oncology Letters
Cancer ResearchOncology
2016English

Proteome Profiling of Low Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Targeting HER2 in Patient-Derived Xenograft Ovarian Cancer Models Sensitizes Tumors to Chemotherapy

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

A miRNA Signature Assessing Ovarian Cancer Prognosis

Oncoscience
Cancer ResearchOncology
2016English

Malignant Ascites: A Source of Therapeutic Protein Against Ovarian Cancer?

Oncotarget
Oncology
2019English

Ovarian Cancer Cells Polarize Macrophages Toward a Tumor-Associated Phenotype

Journal of Immunology
AllergyImmunology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy